The Cure and the Cause

The pharmaceutical industry to which I have returned to is in a pretty bad state. Across the world, the ‘blockbuster’ drugs (those with annual sales above $1 billion) that have fuelled the sector’s growth during the preceding decades are coming to the end of their patent protected lives and with few exceptions there are no … Continue reading